Meijer Ultra Strength Pain Relieving Cream
- Manufacturer
- MEIJER, INC.
- Effective date
- 2022-03-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:04:36
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients Purposes
Camphor 4%...................................Topical analgesic
Menthol 10%...................................Topical analgesic
Methyl salicylate 30%......................Topical analgesic
OTC - PURPOSE SECTION
Uses
temporarily relieves the minor aches and pains of muscles and joints associated with:
- sprains
- simple backache
- arthritis
- strains
- bruises
WARNINGS SECTION
Warnings
For external use only
Allergy alert
If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.
OTC - DO NOT USE SECTION
Do not use
- on wounds or damaged skin
- with a heating pad
- on a child under 12 years of age with arthritis-like conditions
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have redness over the affected area.
OTC - WHEN USING SECTION
When using this product
- do not use otherwise than as directed
- avoid contact with eyes, mucous membranes or rashes
- do not bandage tightly
OTC - STOP USE SECTION
Stop use and ask a doctor if
- redness is present or irritation or rash develops
- condition worsens or symptoms persist for more than 7 days
- symptoms clear up and occur again within a few days
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
INDICATIONS & USAGE SECTION
Directions
- use only as directed
- adults and children 12 years of age and older: apply to affected area not more than 3 to 4 times daily
- children under 12 years of age: ask a doctor
DOSAGE & ADMINISTRATION SECTION
Other Information
- store at room temperature 20-25ºC (68-77ºF)
INACTIVE INGREDIENT SECTION
Inactive ingredients
ethylparaben, glyceryl monostearate, polysorbate 80, purified water, sorbitan monooleate, stearic acid
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 79481-8227-2 | 2022-03-31 | C162847 | 48780-1 | d6a99b39-f8ef-a426-e053-dadaa90af4c2 | Meijer Ultra Strength Pain Relieving Cream 2oz 25350 ZDP |
| 79481-8227-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-f8ef-a426-e053-dadaa90af4c2 | Meijer Ultra Strength Pain Relieving Cream 2oz 25350 ZDP |
Products#
Every source-derived product name is available through these pages.
- Meijer Ultra Strength Pain Relieving Cream
- CAMPHOR, MENTHOL, METHYL SALICYLATE
- METHYL SALICYLATE
- SALICYLIC ACID
- ETHYLPARABEN
- STEARIC ACID
- POLYSORBATE 80
- MENTHOL, UNSPECIFIED FORM
- CAMPHOR (SYNTHETIC)
- GLYCERYL MONOSTEARATE
- WATER
- SORBITAN MONOOLEATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 79481-8227 | 79481-8227-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| METHYL SALICYLATE | LAV5U5022Y | ACTIB |
| ETHYLPARABEN | 14255EXE39 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| MENTHOL, UNSPECIFIED FORM | L7T10EIP3A | ACTIB |
| CAMPHOR (SYNTHETIC) | 5TJD82A1ET | ACTIB |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| WATER | 059QF0KO0R | IACT |
| SORBITAN MONOOLEATE | 06XEA2VD56 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| efe788d9-6658-6232-e053-2a95a90a7bbc | a9f28d36-7edc-44ca-e053-2995a90a82fd | 2022-12-15 | Warnings | a9f28d36-7edc-44ca-e053-2995a90a82fd |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
